ABOUT THIS EVENT
Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, John Kollins, President & CEO, rang the Closing Bell.
Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
September 13, 2019 — 3:30 PM - 4:30 PM ET
Nasdaq MarketSite, 4 Times Square, New York
Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, John Kollins, President & CEO, rang the Closing Bell.